Mirum Pharmaceuticals Inc (NAS:MIRM)
$ 114.2 +1.06 (+0.94%) Market Cap: 6.96 Bil Enterprise Value: 6.90 Bil PE Ratio: 0 PB Ratio: 28.69 GF Score: 50/100

Q1 2026 Mirum Pharmaceuticals Inc Earnings Call Transcript

May 06, 2026 / 08:30PM GMT
Release Date Price: $110.08 (+4.04%)
Operator

Good afternoon, and welcome to Mirum Pharmaceuticals' first quarter 2026 earnings conference call. My name is Tracy, and I will be your operator today.

All lines are currently in a listen-only mode, and there will be an opportunity for Q&A after management's prepared remarks. If you would like to ask a question during that time, press star one to raise your hand.

I would now like to hand the conference over to Andrew McKibben, SVP of Strategic Finance and Investor Relations. Please go ahead.

Andrew Mckibben
Mirum Pharmaceuticals Inc - IR Contact Officer

Thank you, Tracy, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals' first quarter 2026 earnings conference call. For our prepared remarks, I'm joined today by our Chief Executive Officer, Chris Peetz; President and Chief Operating Officer, Peter Radovich; and Erik Vierkoetter, our Chief Financial Officer. Our Chief Medical Officer, Joanne Quan, will be joining us for Q&A.

Earlier this afternoon, Mirum issued a press release reporting our first

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot